Santiago Pediatrics | |
24432 Muirlands Blvd Suite 111 Lake Forest CA 92630-3939 | |
(949) 364-2229 | |
(949) 364-1104 |
Full Name | Santiago Pediatrics |
---|---|
Speciality | Clinic/center - Primary Care |
Location | 24432 Muirlands Blvd, Lake Forest, California |
Authorized Official Name and Position | James Leon Kay (PEDIATRICIAN) |
Authorized Official Contact | 9493642229 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Santiago Pediatrics 24432 Muirlands Blvd Suite 111 Lake Forest CA 92630-3939 Ph: (949) 364-2229 | Santiago Pediatrics 24432 Muirlands Blvd Suite 111 Lake Forest CA 92630-3939 Ph: (949) 364-2229 |
NPI Number | 1558646620 |
---|---|
Provider Enumeration Date | 10/20/2011 |
Last Update Date | 12/16/2014 |
Identifier | Type | State | Issuer |
---|---|---|---|
1558646620 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
News Archive
According to Swiss researchers the dietary supplement chondroitin is no better than a placebo at easing the hip and knee pain of arthritis and they believe its use should be discouraged.
Verenium Corporation, a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced the signing of a $22.5 million secured debt financing with the Athyrium Opportunities Fund ("Athyrium").
The Center for Reproductive Rights on Wednesday during two hearings at a U.S. District Court in New York City asked federal judges to grant a subpoena of White House documents and officials in its lawsuit against FDA over the agency's rejection of Barr Laboratories' first application for nonprescription Plan B sales, Long Island Newsday reports.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.
› Verified 8 days ago
Total Body Healthcare, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 24401 Muirlands Blvd Ste C, Lake Forest, CA 92630 Phone: 949-855-8845 Fax: 949-855-9167 | |
American Current Care Of California, A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22741 Lambert St Ste 1608, Lake Forest, CA 92630 Phone: 949-581-3011 Fax: 949-581-6457 | |
Zoom Therapy Services Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22792 Centre Dr Ste 104, Lake Forest, CA 92630 Phone: 949-606-4681 | |
Vituity Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22855 Lake Forest Dr, Suite A, Lake Forest, CA 92630 Phone: 949-770-1023 | |
Camino Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 22481 Aspan St Ste A, Lake Forest, CA 92630 Phone: 949-240-2030 Fax: 949-429-7627 | |
California Emergency Physicians Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22855 Lake Forest Dr, # A, Lake Forest, CA 92630 Phone: 949-452-7544 | |
California Functional Internal Medicine Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22972 El Toro Rd, Lake Forest, CA 92630 Phone: 949-339-5272 |